Literature DB >> 29372306

[Updates on tumours of the salivary glands : 2017 WHO classification].

S Ihrler1,2, O Guntinas-Lichius3, C Haas4, M Mollenhauer5.   

Abstract

In the new 2017 WHO classification, a reduction of the high number of entities of salivary carcinomas was implemented. There is only one new carcinoma entity: secretory carcinoma. There is a slight increase of reactive and benign entities by the inclusion of rare and well-established, but so far not included, lesions. Furthermore, there are some conceptual changes and pure changes in terminology. The impact of molecular findings is increasing and is so far restricted to diagnostic aspects.

Entities:  

Keywords:  Carcinoma; Molecular pathology; Pleomorphic adenoma; Salivary gland neoplasms; World Health Organization

Mesh：

Year:  2018        PMID： 29372306     DOI： 10.1007/s00292-017-0407-5

Source DB:  PubMed          Journal:  Pathologe        ISSN： 0172-8113            Impact factor:   1.011


  25 in total

1.  Mammary analogue secretory carcinoma of the salivary glands with ETV6-NTRK3 gene fusion.

Authors:  André Fehr; Thomas Löning; Göran Stenman
Journal:  Am J Surg Pathol       Date:  2011-10       Impact factor: 6.394

2.  Salivary duct carcinoma: the predominance of apocrine morphology, prevalence of histologic variants, and androgen receptor expression.

Authors:  Lindsay Williams; Lester D R Thompson; Raja R Seethala; Ilan Weinreb; Adel M Assaad; Madalina Tuluc; Nasir Ud Din; Bibianna Purgina; Chi Lai; Christopher C Griffith; Simion I Chiosea
Journal:  Am J Surg Pathol       Date:  2015-05       Impact factor: 6.394

3.  Carcinoma ex pleomorphic adenoma with special reference to the prognostic significance of histological progression: a clinicopathological investigation of 41 cases.

Authors:  Christoph Weiler; Pamela Zengel; Jacqueline E van der Wal; Orlando Guntinas-Lichius; Stephan Schwarz; John D Harrison; Thomas Kirchner; Stephan Ihrler
Journal:  Histopathology       Date:  2011-10       Impact factor: 5.087

4.  Nonsebaceous lymphadenoma of salivary glands: proposed development from intraparotid lymph nodes and risk of misdiagnosis.

Authors:  Christoph Weiler; Abbas Agaimy; Pamela Zengel; Johannes Zenk; Thomas Kirchner; Stephan Ihrler
Journal:  Virchows Arch       Date:  2012-04-04       Impact factor: 4.064

5.  EWSR1-ATF1 fusion is a novel and consistent finding in hyalinizing clear-cell carcinoma of salivary gland.

Authors:  Cristina R Antonescu; Nora Katabi; Lei Zhang; Yun Shao Sung; Raja R Seethala; Richard C Jordan; Bayardo Perez-Ordoñez; Cherry Have; Sylvia L Asa; Iona T Leong; Grace Bradley; Hagen Klieb; Ilan Weinreb
Journal:  Genes Chromosomes Cancer       Date:  2011-04-11       Impact factor: 5.006

6.  Lipomatous salivary gland tumors: a series of 31 cases spanning their morphologic spectrum with emphasis on sialolipoma and oncocytic lipoadenoma.

Authors:  Abbas Agaimy; Stephan Ihrler; Bruno Märkl; Michael Lell; Johannes Zenk; Arndt Hartmann; Michal Michal; Alena Skalova
Journal:  Am J Surg Pathol       Date:  2013-01       Impact factor: 6.394

Review 7.  Hyalinizing clear cell carcinoma of salivary gland: a review and update.

Authors:  Ilan Weinreb
Journal:  Head Neck Pathol       Date:  2013-07-03

8.  Histological, immunohistological and molecular characteristics of intraductal precursor of carcinoma ex pleomorphic adenoma support a multistep carcinogenic process.

Authors:  Stephan Ihrler; Orlando Guntinas-Lichius; Abbas Agaimy; Agnes Wolf; Martin Mollenhauer
Journal:  Virchows Arch       Date:  2017-03-28       Impact factor: 4.064

9.  Salivary duct carcinomas can be classified into luminal androgen receptor-positive, HER2 and basal-like phenotypes.

Authors:  Silvana Di Palma; Roderick H W Simpson; Caterina Marchiò; Alena Skálová; Marco Ungari; Ann Sandison; Stephen Whitaker; Suzanne Parry; Jorge S Reis-Filho
Journal:  Histopathology       Date:  2012-10       Impact factor: 5.087

10.  Hotspot activating PRKD1 somatic mutations in polymorphous low-grade adenocarcinomas of the salivary glands.

Authors:  Ilan Weinreb; Salvatore Piscuoglio; Luciano G Martelotto; Daryl Waggott; Charlotte K Y Ng; Bayardo Perez-Ordonez; Nicholas J Harding; Javier Alfaro; Kenneth C Chu; Agnes Viale; Nicola Fusco; Arnaud da Cruz Paula; Caterina Marchio; Rita A Sakr; Raymond Lim; Lester D R Thompson; Simion I Chiosea; Raja R Seethala; Alena Skalova; Edward B Stelow; Isabel Fonseca; Adel Assaad; Christine How; Jianxin Wang; Richard de Borja; Michelle Chan-Seng-Yue; Christopher J Howlett; Anthony C Nichols; Y Hannah Wen; Nora Katabi; Nicholas Buchner; Laura Mullen; Thomas Kislinger; Bradly G Wouters; Fei-Fei Liu; Larry Norton; John D McPherson; Brian P Rubin; Blaise A Clarke; Britta Weigelt; Paul C Boutros; Jorge S Reis-Filho
Journal:  Nat Genet       Date:  2014-09-21       Impact factor: 38.330
View more
  2 in total

1.  [Myoepithelial carcinoma of the parotid gland: a rare tumor with diagnostic challenges].

Authors:  Elias Tenner; Edda Menke-Lechner; Stefan Edlinger; Melitta Kitzwoegerer; Georg Sprinzl
Journal:  Wien Med Wochenschr       Date:  2021-01-29

Review 2.  Targeted Therapy, Chemotherapy, Immunotherapy and Novel Treatment Options for Different Subtypes of Salivary Gland Cancer.

Authors:  Sarina K Mueller; Marlen Haderlein; Sebastian Lettmaier; Abbas Agaimy; Florian Haller; Markus Hecht; Rainer Fietkau; Heinrich Iro; Konstantinos Mantsopoulos
Journal:  J Clin Med       Date:  2022-01-29       Impact factor: 4.241
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.